Chemical genetics uncovers promising anti-COVID compounds

This new article publication from Acta Pharmaceutica Sinica B, discusses the identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics.

HitGen and SGC enter drug discovery partnership

HitGen’s OpenDEL platform can be used for running affinity screening experiments against protein targets. Credit: Gorodenkoff/Shutterstock.com. Chinese company HitGen and the Structural Genomics Consortium (SGC)

September 29, 2023

Opinion | Is Industry Influence Driving LVAD Use by Cardiologists?

Dhruva is an assistant professor of medicine. Ross is a professor of medicine and public health. As physicians, our patients and their caregivers expect that

April 27, 2024

Significant increase in earnings – full-year forecast raised – Biotech Investments

Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/Change in Forecast Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings

October 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.